Pfizer, BioNTech seek emergency use of COVID-19 vaccine in US

1,014FollowersFollow

U.S. drugmaker, Pfizer Inc., and German company BioNTech SE, on Friday, asked regulators in the United States to allow emergency use of their COVID-19 vaccine.

If the Federal Drug Administration (FDA) approves their request, both companies will start distributing their vaccine as early as next month.

Pfizer Inc. on Wednesday said final data on its coronavirus vaccine candidate, developed with German company BioNTech SE, showed it to be 95 percent effective, a week after it said interim data revealed the vaccine to be 90 percent effective.

Pfizer said on Wednesday it had the two months of safety data necessary to apply for an emergency use authorization from the FDA.

BioNtech, the German company, will also apply for approval from EUA and both companies will share data with other regulatory agencies around the globe.

Both companies expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses by the end of 2021.

On Monday, Pfizer said it was starting a pilot program to deliver its experimental vaccine to four U.S. states – New Mexico, Texas, Rhode Island and Tennessee.

The announcement was made the same day Moderna, another American drug company said interim data revealed its own coronavirus candidate to be 94.5 percent effective, and that it will be applying for FDA approval in the coming weeks after obtaining final safety and efficacy data.

Pfizer did not receive development funds from the Donald Trump administration through its Operation Warp Speed, but Moderna was given $955 million for the development of its vaccine.

Vaccine efficacy

Pfizer said its vaccine candidate is 95 percent effective “against COVID-19 beginning 28 days after the first dose.”

It said the efficacy rate was consistent across age, gender, race and ethnicity groups.

The company added that for adults older than 65, who are at greater risk of dying from COVID-19, the efficacy rate was also more than 95 percent.

Pfizer said about 43,000 participants enrolled in its vaccine candidate trial, and 170 people came down with the coronavirus.

Among those who tested positive for coronavirus were 162 people who received the placebo or ‘fake vaccine’ and only 8 people who received the ‘real vaccine’, numbers that informed its 95 percent rate efficacy.

It said no serious safety concerns were observed, adding that the only Grade 3 adverse event greater than 2% in frequency was fatigue at 3.8% and headache at 2.0%.

“The study results mark an important step in this historic eight-month journey to bring forward a vaccine capable of helping to end this devastating pandemic. We continue to move at the speed of science to compile all the data collected thus far and share with regulators around the world,” said Dr. Albert Bourla, Pfizer Chairman and CEO. “With hundreds of thousands of people around the globe infected every day, we urgently need to get a safe and effective vaccine to the world.”

If approved, health care workers and other higher risk populations will be prioritized in the distribution beginning in December.

Dr. Anthony Fauci and other health experts have said the vaccine will not likely reach the general public until about April next year.

Simon Ateba
Simon Ateba
Based in Washington, District of Columbia, United States of America, Simon leads a brilliant team of reporters, freelance journalists, analysts, researchers and contributors from around the world to run TODAY NEWS AFRICA as editor-in-chief. Simon Ateba's journalistic experience spans over 10 years and covers many beats, including business and investment, information technology, politics, diplomacy, human rights, science reporting and much more. Write him: simonateba@todaynewsafrica.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Now

Biden announces foreign policy and national security team, including Blinken as Secretary of State, Mayorkas as Secretary of Homeland Security and Kerry as envoy on climate

U.S. President-elect Joe Biden on Monday announced key members of his foreign policy and national security team, including Antony Blinken as Secretary of State;...

Trump campaign files appeal after Judge called legal claim in Pennsylvania “Frankenstein’s Monster” before dismissing it

President Donald Trump’s legal team on Sunday filed an appeal to a federal judge’s ruling that dismissed his campaign's effort to block the certification...

President-elect Joe Biden’s national security and foreign policy team praised as experienced and historic choices

U.S. President-elect Joe Biden announced key members of his national security and foreign policy team on Monday, including Antony Blinken as Secretary of State;...

Ethiopian forces set to take Tigrayan capital, as many fear mass civilian deaths

The Ethiopian military said late on Friday that government forces were set to take control of Mekelle, the regional capital of Tigray, even as...

Linda Thomas-Greenfield: “America is back. Multilateralism is back. Diplomacy is back.”

Linda Thomas-Greenfield, who has been nominated by President-elect, Joseph R. Biden Jr., to serve as the United States Ambassador to the United Nations, on...

U.S. calls for independent probe into massacres in Tigray region in Ethiopia

The United States government on Thursday called for an independent investigation following massacres in the Tigray region in Ethiopia. The United States said the investigation...

Biden delivers inspiring thanksgiving message to the nation, urges Americans to come together, defeat COVID-19 and dream again

U.S. President-elect Joseph R. Biden Jr. on Wednesday delivered an inspiring thanksgiving message to the nation, urged Americans to come together, defeat COVID-19 and...

Biden to use walking boot for several weeks after sustaining fractures while playing with dog, doctor says

U.S. President-elect Joe Biden sustained a sprain of his right foot while playing with his dog, Major, his doctor said on Sunday. "Initial X-rays are...

Biden fractured several bones while playing with his dog, doctor says

U.S. President-elect Joe Biden sustained a sprain of his right foot while playing with his dog, Major, his doctor said on Sunday. "Initial X-rays are...

Biden appoints Jen Psaki White House Press Secretary, announces other communications positions

President-elect Joe Biden and Vice President-elect Kamala Harris on Sunday announced new members of the White House staff who will serve in senior communications...

President-elect Joe Biden slips while playing with dog, twists ankle

U.S. President-elect Joseph R. Biden Jr. slipped while playing with his dog, Major, on Saturday, and twisted his ankle. The President-elect is being examined at...

Biden expands lead in Wisconsin by 87 votes after Trump spent $3 million for recount

U.S. President-elect Joe Biden on Sunday expanded his lead in Wisconsin after Donald Trump spent $3 million for a recount in two of the...

Joe Biden will need to strengthen ties with Africa, says Navy SEAL admiral McRaven

President-elect Joseph R. Biden Jr. will need to "play the long game" by strengthening ties with the rest of the world, including the continent...

Pennsylvania Supreme Court allows state to complete certification of Biden win

The Supreme Court in Pennsylvania on Saturday allowed the state to complete the certification of its presidential vote won by President-elect Joseph R. Biden...

Biden to use walking boot for several weeks after sustaining fractures while playing with dog, doctor says

U.S. President-elect Joe Biden sustained a sprain of his right foot while playing with his dog, Major, his doctor said on Sunday. "Initial X-rays are reassuring that there is no obvious fracture and he will be getting an additional CT for more detailed imaging," Dr. Kevin O’Connor, Director, Executive Medicine, GW Medical Faculty Associates, said in a statement. After Biden received his additional CT on Sunday evening,...
error: Alert: Content is protected !!
Share
Tweet
WhatsApp
Pin
Share